News - Page 107 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article CB Therapeutics granted a new patent that will help further provide eco-conscious avenues for psychedelic research

CB Therapeutics granted a new patent that will help further provide eco-conscious avenues for psychedelic research

Post published:May 19, 2022
Post category:Press Release

Read more about the article GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates

GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates

Post published:May 18, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin #102 – Our Analysis of MindMed’s LSD for Anxiety Results; Mail-Order Ketamine May Come Under Scrutiny; Our Notes from PSYCH Symposium

Psychedelic Bulletin #102 – Our Analysis of MindMed’s LSD for Anxiety Results; Mail-Order Ketamine May Come Under Scrutiny; Our Notes from PSYCH Symposium

Post published:May 16, 2022
Post category:Psychedelic Bulletin

Read more about the article Universal Ibogaine Co-Founder Dr Alberto Sola to Present at upcoming Research to Reality Conference

Universal Ibogaine Co-Founder Dr Alberto Sola to Present at upcoming Research to Reality Conference

Post published:May 13, 2022
Post category:Press Release

Read more about the article Psychedelic Research Bulletin: April 2022

Psychedelic Research Bulletin: April 2022

Post published:May 12, 2022
Post category:Psychedelics Research Review

Read more about the article Psychedelic Bulletin #101 – Psychedelic R&D in the UK; COMPASS Study Points to Psilocybin for Anorexia

Psychedelic Bulletin #101 – Psychedelic R&D in the UK; COMPASS Study Points to Psilocybin for Anorexia

Post published:May 6, 2022
Post category:Psychedelic Bulletin

Read more about the article Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

Post published:May 2, 2022
Post category:Press Release

Psilocybin Alpha is now Psychedelic Alpha

Post published:April 28, 2022
Post category:Announcements

Read more about the article MINDCURE Announces Financial Results for the Third Quarter of Fiscal 2022

MINDCURE Announces Financial Results for the Third Quarter of Fiscal 2022

Post published:April 26, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin: Psychedelics X Big Pharma; $23m Round for At-Home Ketamine Therapy; Psychedelics Research Review

Psychedelic Bulletin: Psychedelics X Big Pharma; $23m Round for At-Home Ketamine Therapy; Psychedelics Research Review

Post published:April 25, 2022
Post category:Psychedelic Bulletin

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.